Filters

Latest News

2021-03-09 17:00:38

Meeting discusses COVID-19 vaccine manufacturing bottlenecks that must be urgently tackled for C19 vaccine output to reach its full potential

9 March 2021: Chatham House, in collaboration with COVAX, IFPMA, DVCMN, and BIO, convened a Global COVID-19 Vaccine Supply Chain & ...

Read More

2021-02-18 14:00:30

The AMR Action Fund announces its first non-industry investments, raising an additional US$140 million toward addressing antimicrobial resistance (AMR)

The AMR Action Fund, launched in July 2020, aims to bring 2 to 4 new ...

Read More

2021-02-18 14:00:21

The AMR Action Fund announces appointment of CEO, Henry B. Skinner, PhD

Dr. Skinner will help ensure the AMR Action Fund achieves its mission to bring two ...

Read More

2021-02-05 15:02:40

Patients, product development partnerships and private health sector representatives call for the rapid ratification of the African Medicines Agency Treaty to speed up timelines to vaccines and medicines approval

London / Geneva, 5 February 2021 – On the eve of the 34th African Union ...

Read More

2021-01-25 07:00:01

Biopharmaceutical global body kicks off 2021 with new CEO leadership line up

Geneva, 25 January 2021 –The biopharmaceutical global industry, represented by the International Federation of Pharmaceutical Manufacturers ...

Read More

2021-01-12 11:27:48

Speak Up Africa and IFPMA start their search for winners of the Africa Young Innovators for Health Award

The Africa Young Innovators for Health Award is IFPMA and Speak Up Africa’s flagship programme ...

Read More

2020-12-08 12:45:58

Speak Up Africa and IFPMA launch the “Africa Young Innovators for Health Award” to fuel innovation and help advance promising healthcare solutions

The first edition of the “Africa Young Innovators for Health Award” aims to support entrepreneurs ...

Read More

Latest Statement

2021-04-15 10:41:32

IFPMA statement at WTO event “COVID-19 and Vaccine Equity: What can the WTO Contribute”

On 14 April 2021, IFPMA and a number of its member company experts attended the WTO event “COVID-19 and Vaccine ...

Read More

2021-04-09 17:36:46

BIO-IFPMA Comment on COVAX No-Fault Compensation Program for COVAX Advance Market Commitment Eligible Economies

The first edition of the “Africa Young Innovators for Health ...

Read More

2021-03-30 18:20:03

COVID-19 vaccine and treatment innovators response to global leaders urgent call for international pandemic treaty

The first edition of the “Africa Young Innovators for Health ...

Read More

2021-02-05 15:11:21

Call to Heads of State of the African Union to Ratify the African Medicines Agency Treaty

The first edition of the “Africa Young Innovators for Health ...

Read More

2021-01-29 20:47:55

IFPMA Statement on EU COVID-19 Vaccines Supply

The first edition of the “Africa Young Innovators for Health ...

Read More

2021-01-20 11:00:22

IFPMA, GSCF, ICBA Joint Statement on the item 14.2 Strengthening preparedness for health emergencies: implementation of the IHR @EB148

The first edition of the “Africa Young Innovators for Health ...

Read More

2021-01-19 08:25:31

IFPMA Statement for EB148 agenda item 14.1 Covid-19 Response

The first edition of the “Africa Young Innovators for Health ...

Read More

mailto:a.jones@ifpma.org

Abigail Jones - Director, Communications

Abigail Jones is responsible for communications at IFPMA. She joined IFPMA after over 25 years in international communications and public affairs consultancy, where she worked for many blue-chip companies, trade associations, think tanks, coalition and advocacy groups. Abigail supported the launches and ongoing work of the Fight the Fakes campaign, AMR Industry Alliance and Pat-INFORMED.

mailto:m.depol@ifpma.org
Twitter @MorganePol

Morgane De Pol - Deputy Director, Communications

Morgane develops and implements public affairs programs that build trust, dialogue and collaboration between the innovative biopharmaceutical industry and other global players in the health community. Morgane has international experience in developing and rolling-out integrated advocacy and communications strategies in the global health sector, with specific focus on institutional communications, media relations, alliance building and event management.

A shared commitment to global health

Our Brouchure

2015 Edition

A shared commitment to global health

At IFPMA we advocate policies and practices that encourage the discovery of and access to life-saving and life-enhancing medicines and vaccines, for people everywhere.


Our Logo

Full colour EPS format

Our Logo

Full colour PNG format


FULL Name LOGO

Full colour EPS format


FULL Name LOGO

Full colour PNG format

News Release

meeting-discusses-covid-19-vaccine-manufacturing-bottlenecks-that-must-be-urgently-tackled-for-c19-vaccine-output-to-reach-its-full-potential

Meeting discusses COVID-19 vaccine manufacturing bottlenecks that must be urgently tackled for C19 vaccine output to reach its full potential

9 March 2021: Chatham House, in collaboration with COVAX, IFPMA, DVCMN, and BIO, convened a Global COVID-19 Vaccine Supply Chain & Manufacturing Summit on 8th and 9th March. The unprecedented scaling up of vaccine manufacturing, from zero to billions of

Read More

Our Blog

Latest Tweets

From the perspective of the innovative biopharma industry, there are 3 components to achieving #UHC: 1⃣ uphold qua… https://t.co/wNpWiLF6SE
RT @ABPI_UK: Collaboration is at the heart of the G7 and has been central to our collective response to the COVID-19 pandemic. Our response…
2
Launching today, a new Pandemic Preparedness Partnership will bring together industry, experts and international or… https://t.co/gvbqZQXh3B
2 6
#COVID19 has disrupted many diseases related services. Our members and partners keep working on the many health thr… https://t.co/MzbMtMJMFl
1
We 're thrilled to announce our participation in the @BP2Convince Workplace Challenge! As a Partner, we agree to pr… https://t.co/Jr1JNl7ylU
1 3